日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab

对接受多西他赛/泼尼松联合或不联合贝伐珠单抗治疗的转移性去势抵抗性前列腺癌男性患者循环血浆生物标志物的预后和预测分析

Nixon, Andrew B; Liu, Yingmiao; Yang, Qian; Luo, Bin; Starr, Mark D; Brady, John C; Kelly, Wm Kevin; Beltran, Himisha; Morris, Michael J; George, Daniel J; Armstrong, Andrew J; Halabi, Susan

Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants

健康参与者血管组生物标志物生物学变异性随时间变化的特征分析

Liu, Yingmiao; Li, Jiatong; Lyu, Jing; Howard, Lauren E; Sibley, Alexander B; Starr, Mark D; Brady, John C; Arrowood, Christy; Kohn, Elise C; Ivy, S Percy; Hurwitz, Herbert I; Abbruzzese, James L; Owzar, Kouros; Nixon, Andrew B

A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers

一项初步研究,旨在调查帕博利珠单抗对新诊断的苗勒氏管癌肿瘤免疫表型的影响

Gaillard, Stéphanie L; Broadwater, Gloria; Berchuck, Andrew; Andrews, William S; Havrilesky, Laura J; Davidson, Brittany A; Previs, Rebecca A; Starr, Mark D; Yi, John S; Nixon, Andrew B; Neff, Jadee L; Conejo-Garcia, Jose Ramon; Secord, Angeles Alvarez

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

IFNα ± 贝伐单抗治疗转移性肾细胞癌患者的总生存期预测生物标志物:CALGB 90206 (Alliance) 研究结果

Nixon, Andrew B; Halabi, Susan; Liu, Yingmiao; Starr, Mark D; Brady, John C; Shterev, Ivo; Luo, Bin; Hurwitz, Herbert I; Febbo, Phillip G; Rini, Brian I; Beltran, Himisha; Small, Eric J; Morris, Michael J; George, Daniel J

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

接受贝伐单抗或西妥昔单抗化疗的晚期或转移性结直肠癌患者的血浆蛋白生物标志物:CALGB 80405(联盟)研究结果

Nixon, Andrew B; Sibley, Alexander B; Liu, Yingmiao; Hatch, Ace J; Jiang, Chen; Mulkey, Flora; Starr, Mark D; Brady, John C; Niedzwiecki, Donna; Venook, Alan P; Baez-Diaz, Luis; Lenz, Heinz-Josef; O'Neil, Bert H; Innocenti, Federico; Meyerhardt, Jeffrey A; O'Reilly, Eileen M; Owzar, Kouros; Hurwitz, Herbert I

Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)

晚期或转移性肾细胞癌患者中阿昔替尼联合 TRC105 与阿昔替尼单药治疗的临床结果和生物标志物分析 (TRAXAR)

Choueiri, Toni K; Zakharia, Yousef; Pal, Sumanta; Kocsis, Judit; Pachynski, Russell; Poprach, Alexandr; Nixon, Andrew B; Liu, Yingmiao; Starr, Mark; Lyu, Jing; Owzar, Kouros; deShazo, Mollie; Lara, Primo; Geczi, Lajos; Ho, Thai H; Walsh, Meghara; Adams, Bonne; Robertson, Liz; Darif, Mohamed; Theuer, Charles; Agarwal, Neeraj

Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations

循环血管生成和炎症生物标志物与血管畸形相关的初步研究

Wetzel-Strong, Sarah E; Weinsheimer, Shantel; Nelson, Jeffrey; Pawlikowska, Ludmila; Clark, Dewi; Starr, Mark D; Liu, Yingmiao; Kim, Helen; Faughnan, Marie E; Nixon, Andrew B; Marchuk, Douglas A

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

预测性血液生物标志物在接受卡铂和紫杉醇联合或不联合贝伐单抗治疗的上皮性卵巢癌患者中的应用:GOG-0218 研究结果

Alvarez Secord, Angeles; Bell Burdett, Kirsten; Owzar, Kouros; Tritchler, David; Sibley, Alexander B; Liu, Yingmiao; Starr, Mark D; Brady, J Chris; Lankes, Heather A; Hurwitz, Herbert I; Mannel, Robert S; Tewari, Krishnansu S; O'Malley, David M; Gray, Heidi; Bakkum-Gamez, Jamie N; Fujiwara, Keiichi; Boente, Matthew; Deng, Wei; Burger, Robert A; Birrer, Michael J; Nixon, Andrew B

Heavy marijuana use but not deprivation is associated with increased stressor reactivity

大量吸食大麻(而非戒断)与压力反应性增强有关。

Hefner, Kathryn R; Starr, Mark J; Curtin, John J

Empirically based comparisons of the reliability and validity of common quantification approaches for eyeblink startle potentiation in humans

基于实证研究的常用量化方法在人类眨眼惊吓增强效应中的可靠性和有效性比较

Bradford, Daniel E; Starr, Mark J; Shackman, Alexander J; Curtin, John J